VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR)
CUSIP: 929033108
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 64,015,196
- Total 13F shares
- 60,203,525
- Share change
- +28,575,739
- Total reported value
- $400,322,462
- Put/Call ratio
- 5.5%
- Price per share
- $6.65
- Number of holders
- 58
- Value change
- +$191,043,574
- Number of buys
- 40
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 929033108?
CUSIP 929033108 identifies VOR - VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 929033108:
Top shareholders of VOR - VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
17%
|
11,120,973
|
$44,261,000 | — | 30 Sep 2022 | |
| 5AM Venture Management, LLC |
13F
|
Company |
9.9%
|
6,361,723
|
$25,320,000 | — | 30 Sep 2022 | |
| FMR LLC |
13F
|
Company |
5%
|
3,181,235
|
$12,661,000 | — | 30 Sep 2022 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
2.7%
|
1,703,645
|
$6,781,000 | — | 30 Sep 2022 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.3%
|
1,465,925
|
$5,834,000 | — | 30 Sep 2022 | |
| Woodline Partners LP |
13F
|
Company |
1.7%
|
1,111,123
|
$4,422,000 | — | 30 Sep 2022 | |
| JOHNSON & JOHNSON |
13F
|
Company |
1.7%
|
1,074,658
|
$4,277,000 | — | 30 Sep 2022 | |
| Laurion Capital Management LP |
13F
|
Company |
1.3%
|
857,308
|
$3,412,000 | — | 30 Sep 2022 | |
| 5AM Ventures VI, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,766,634
|
$3,215,274 | — | 16 Nov 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1%
|
657,142
|
$2,616,000 | — | 30 Sep 2022 | |
| Sarissa Capital Management LP |
13F
|
Company |
0.97%
|
618,000
|
$2,460,000 | — | 30 Sep 2022 | |
| Artal Group S.A. |
13F
|
Company |
0.86%
|
550,000
|
$2,189,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.68%
|
437,621
|
$1,742,000 | — | 30 Sep 2022 | |
| OUP Management Co., LLC |
13F
|
Company |
0.59%
|
374,714
|
$1,491,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.53%
|
338,921
|
$1,349,000 | — | 30 Sep 2022 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.47%
|
302,412
|
$1,204,000 | — | 30 Sep 2022 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.4%
|
255,162
|
$1,016,000 | — | 30 Sep 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.33%
|
209,500
|
$834,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.21%
|
135,598
|
$539,000 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.2%
|
129,080
|
$514,000 | — | 30 Sep 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.17%
|
111,808
|
$445,000 | — | 30 Sep 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
79,400
|
$316,000 | — | 30 Sep 2022 | |
| Ergoteles LLC |
13F
|
Company |
0.1%
|
65,332
|
$260,000 | — | 30 Sep 2022 | |
| Bollard Group LLC |
13F
|
Company |
0.09%
|
55,555
|
$221,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.07%
|
46,660
|
$186,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
41,213
|
$164,000 | — | 30 Sep 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.05%
|
32,945
|
$131,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.05%
|
31,900
|
$127,000 | — | 30 Sep 2022 | |
| LMR Partners LLP |
13F
|
Company |
0.04%
|
26,768
|
$107,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
23,074
|
$92,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
22,397
|
$89,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
19,062
|
$76,000 | — | 30 Sep 2022 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.02%
|
14,549
|
$66,000 | — | 30 Sep 2022 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.02%
|
14,834
|
$59,000 | — | 30 Sep 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.02%
|
14,606
|
$58,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.02%
|
10,875
|
$44,000 | — | 30 Sep 2022 | |
| BOURGEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.02%
|
10,700
|
$43,000 | — | 30 Sep 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
10,412
|
$41,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
7,571
|
$30,000 | — | 30 Sep 2022 | |
| NISA INVESTMENT ADVISORS, LLC |
13F
|
Company |
0.01%
|
3,900
|
$19,000 | — | 30 Sep 2022 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
3,433
|
$13,000 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,698
|
$7,000 | — | 30 Sep 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,572
|
$6,000 | — | 30 Sep 2022 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
446
|
$2,000 | — | 30 Sep 2022 | |
| China Universal Asset Management Co., Ltd. |
13F
|
Company |
0%
|
356
|
$1,000 | — | 30 Sep 2022 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
250
|
$1,000 | — | 30 Sep 2022 | |
| Eagle Bay Advisors LLC |
13F
|
Company |
0%
|
150
|
$1,000 | — | 30 Sep 2022 | |
| Christopher Slapak |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
116,000
|
— | — | 01 Feb 2022 | |
| Kush Parmar |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
16,911
|
— | — | 14 Jun 2022 |
Institutional Holders of VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR) as of Q4 2022
As of 31 Dec 2022,
VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,203,525 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., FMR LLC, Paradigm Biocapital Advisors LP, 5AM Venture Management, LLC, Laurion Capital Management LP, Artal Group S.A., JANUS HENDERSON GROUP PLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, and Woodline Partners LP.
This page lists
58
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
45
Q4 2022 holders
58
Holder diff
13
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.